Genmab Ownership | Who Owns Genmab?
Genmab Ownership Summary
Genmab is owned by 4.63% institutional investors, and 95.37% retail investors. Blackrock is the largest institutional shareholder, holding 7.78% of GMAB shares. AllianceBernstein US L/C Growth Eqty MF is the top mutual fund, with 0.93% of its assets in Genmab shares.
GMAB Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Genmab | 4.63% | - | 95.37% |
| Sector | Healthcare Stocks | 42.54% | 10.82% | 46.64% |
| Industry | Biotech Stocks | 45.21% | 10.75% | 44.04% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 5.08M | 7.78% | $127.67M |
| Orbis allan gray | 11.08M | 1.79% | $339.76M |
| Alliancebernstein | 10.95M | 1.77% | $335.96M |
| Bank of america corp /de/ | 1.10M | 1.68% | $27.57M |
| Millennium management | 927.75K | 1.43% | $19.36M |
| Paradigm biocapital advisors lp | 3.82M | 0.62% | $117.06M |
| Arrowstreet capital, limited partnership | 3.64M | 0.59% | $111.74M |
| Harding loevner lp | 3.48M | 0.56% | $106.86M |
| Blackrock funding, inc. /de | 3.45M | 0.56% | $105.83M |
| Renaissance | 2.82M | 0.46% | $86.54M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Ikarian capital | 175.00K | 5.35% | $53.02M |
| Paradigm biocapital advisors lp | 3.82M | 3.33% | $117.06M |
| Avidity partners management lp | 248.10K | 1.73% | $7.61M |
| Aimz investment advisors | 164.51K | 1.58% | $5.05M |
| Orbis allan gray | 11.08M | 1.46% | $339.76M |
| Private wealth advisors | 148.34K | 1.12% | $3.06M |
| Harding loevner lp | 3.48M | 0.78% | $106.86M |
| Virtus etf advisers | 27.50K | 0.55% | $843.27K |
| Deep track capital, lp | 481.27K | 0.41% | $14.76M |
| Legacy wealth asset management | 46.59K | 0.35% | $1.43M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Paradigm biocapital advisors lp | 3.82M | 3.33% | 3.82M |
| Orbis allan gray | 11.08M | 1.46% | 3.16M |
| Harding loevner lp | 3.48M | 0.78% | 561.05K |
| Deep track capital, lp | 481.27K | 0.41% | 481.27K |
| Fmr | 1.12M | 0.00% | 439.18K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Capital investors | - | - | -2.57M |
| Wellington management group llp | - | - | -2.31M |
| Marshall wace, llp | 533.21K | 0.02% | -1.37M |
| Morgan stanley | 1.67M | 0.00% | -1.02M |
| Voloridge investment management | 130.81K | 0.01% | -818.36K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Paradigm biocapital advisors lp | 3.82M | 3.33% | 3.82M | $117.06M |
| Deep track capital, lp | 481.27K | 0.41% | 481.27K | $14.76M |
| Federated hermes | 422.94K | 0.02% | 422.94K | $12.97M |
| Cibc world market | 279.93K | 0.02% | 279.93K | $8.59M |
| Ikarian capital | 175.00K | 5.35% | 175.00K | $53.02M |
Sold Out
| Holder | Change |
|---|---|
| Zurcher kantonalbank (zurich cantonalbank) | -1.00 |
| Deutsche bank ag\ | -4.00 |
| Group one trading | -8.00 |
| Mendota financial group | -8.00 |
| Baillie gifford | -12.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 179 | -15.96% | 28,573,191 | -37.70% | 4 | 0.09% | 120 | 5.26% | 40 | -44.44% |
| Jun 30, 2025 | 219 | -3.52% | 63,692,065 | -1.88% | 99 | 0.96% | 116 | -11.45% | 74 | 12.12% |
| Mar 31, 2025 | 226 | -2.59% | 64,889,241 | 6.75% | 101 | 1.16% | 129 | 3.20% | 67 | -10.67% |
| Dec 31, 2024 | 154 | -31.56% | 35,827,984 | -31.48% | 55 | 0.85% | 73 | -42.52% | 59 | -9.23% |
| Sep 30, 2024 | 224 | 1.36% | 52,289,656 | 7.32% | 80 | 1.43% | 126 | 32.63% | 65 | -29.35% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| AllianceBernstein US L/C Growth Eqty MF | 5.71M | 0.93% | - |
| AB Large Cap Growth A | 4.10M | 0.67% | - |
| iShares Biotechnology ETF | 2.42M | 0.39% | - |
| Vanguard Health Care Inv | 2.29M | 0.36% | - |
| T. Rowe Price International Gr Eq SMA | 1.90M | 0.30% | 1.90M |
| First Trust NYSE Arca Biotech ETF | 1.59M | 0.26% | - |
| AB US Large Cap Growth CT B | 1.39M | 0.23% | - |
| AB American Growth AX USD | 1.19M | 0.19% | -52.71K |
| American Growth One D | 1.19M | 0.19% | -47.56K |
| Xtrackers S&P 500 Swap ETF 1C | 1.02M | 0.16% | 1.02M |
GMAB Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools